Clinical trials
Observational Genetic Predisposition to Disease trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
29 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2003 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2008 | 1 |
| 2011 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 5 |
| 2020 | 3 |
| 2021 | 5 |
| 2022 | 4 |
| 2023 | 1 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 29 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fudan University | 2 |
| Hospices Civils de Lyon | 2 |
| Afyonkarahisar Health Sciences University | 1 |
| Centre Georges Francois Leclerc | 1 |
| Cervical Artery Dissections and Ischemic Stroke Patients - Consortium | 1 |
| Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 1 |
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 1 |
| Hospital Alemão Oswaldo Cruz | 1 |
| Lithuanian University of Health Sciences | 1 |
| M.D. Anderson Cancer Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Genetic Predisposition to Disease | 29 |
| COVID-19 | 3 |
| Genetic Risk Score | 3 |
| Inflammation | 3 |
| Stroke | 3 |
| Atrial Fibrillation | 2 |
| Breast Neoplasms | 2 |
| Coronary Artery Disease | 2 |
| Neoplasms | 2 |
| Anencephaly | 1 |
Trials
Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.